DYOR. This comparative analysis is not intended as financial advice. You are encouraged to do your own research and make your own investment decisions. Disclosures - held, sentiment bullish/long. This is my own analysis and I have not received compensation for it.Due to strength of the results I am lifting probability for the Breast Cancer trials to 40%.
This lifts the value of the Pillar 2 to $37.71 and my current assessment of risked fair value for buyout to $76.
Do your own research on the history of Bisantrene and look at the probabilities I have used and make your own assessment of whether the probabilities I have used are realistic.
Please read with reference to the following post for explanation of how the estimate was put together:
https://hotcopper.com.au/posts/51579160/single
Ann: Compelling Preclinical Breast Cancer Results, page-167
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |